Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels
A completed clinical trial update assessing whether phases of the menstrual cycle influence blood levels of lithium and sertraline in indivi…
-
CLINICAL_TRIALS withdrawal · 2017-02-17Clinical Trial Update: Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy [NA]
This clinical trial update reports the withdrawal of a Kaiser Permanente study evaluating ultrabrief right unilateral and brief-pulse electr…
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder [Phase 1]
Phase 1 safety and tolerability study of FK949E in adults with major depressive disorder has been completed.
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECT [NA]
This clinical trial update reports results for adding mifepristone to bilateral electroconvulsive therapy in patients with non-psychotic maj…
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder [Phase 1]
This completed Phase 1 study evaluated the safety and tolerability of FK949E in elderly patients with major depressive disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-02-16Clinical Trial Update: Oral Multiple-dose Study in Patients With Major Depressive Disorder [Phase 1]
Phase 1 oral multiple-dose study in adults with Major Depressive Disorder sponsored by Astellas Pharma Inc has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study [Phase 4]
Phase 4 trial evaluating paroxetine plus bupropion for depression with suicidal ideation; results were posted in 2017 and included an fMRI s…
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Insulin Resistance in Patients With Mood Disorder [NA]
This clinical trial update reports completion and posted results of a study exploring insulin resistance in patients with mood disorders, in…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder [Phase 4]
Phase 4 study investigating predictors of response to augmentation with ziprasidone (Geodon) in major depressive disorder, with results post…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features
This terminated clinical trial investigated the risk of insulin resistance and metabolic syndrome in individuals with major depressive disor…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Social Work Intervention Focused on Transitions [NA]
Clinical trial update for a social work–driven care transitions intervention to reduce 30-day rehospitalizations among at-risk older adults;…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: An fMRI Study on Temporal Discounting in Bipolar Disorder
This is a completed clinical trial from Massachusetts General Hospital using fMRI to study temporal discounting in individuals with bipolar …
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Intranasal Ketamine in Treatment-Resistant Depression [NA]
Completed clinical trial investigating intranasal ketamine for treatment-resistant depression. Results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD [Phase 3]
This update reports results from a 6-month open-label extension of a Phase 3 pediatric major depressive disorder study evaluating DVS SR, fo…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: The Effect of Exercise on Mood After Traumatic Brain Injury [NA]
A completed clinical trial evaluating whether exercise impacts mood in individuals with traumatic brain injury, including depressive symptom…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: A Study of Nociceptin/Orphanin FQ Peptide Receptor Occupancy in Healthy Subjects [Phase 1]
Phase 1 study evaluating occupancy of the nociceptin/orphanin FQ peptide receptor in healthy subjects; the trial sponsored by BlackThorn The…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: A Study of LY2940094 in Major Depressive Disorder [Phase 1]
A Phase 1 study evaluating LY2940094 for Major Depressive Disorder has completed.
-
CLINICAL_TRIALS research · 2017-02-03Clinical Trial Update: Computerized Cognitive Remediation for Geriatric Depression [NA]
Clinical trial update on computerized cognitive remediation for geriatric depression sponsored by Weill Medical College of Cornell Universit…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD) [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of LY2940094 in adults with major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: Transcranial Electrical Stimulation (TES) for the Treatment of Depression. [NA]
The clinical trial evaluating transcranial electrical stimulation (TES) as a treatment for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: Theta Burst Study Ghent [NA]
The study NCT01832805 from University Ghent evaluating theta burst stimulation for unipolar major depression has completed.
-
FDA approval · 2017-02-01FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for aripiprazole (generic ARIPIPRAZOLE) from Amneal Pharmaceuticals LLC, authorizing the generic for…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Treatment Resistant Geriatric Depression in Primary Care [Phase 1]
This Phase 1 trial investigates treatment-resistant major depressive disorder in geriatric patients in primary care. The study has completed…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Self-Defense Training in Women With Trauma [NA]
This clinical trial update reports the completion and results posting of a study on self-defense training for women with trauma, examining e…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Effects of tDCS on Cognitive Control and Emotion Regulation in Depressed Patients [NA]
An update on a clinical trial evaluating the effects of anodal transcranial direct current stimulation on cognitive control and emotion regu…